Is prophylactic beta-adrenergic blockade appropriate in mitral regurgitation: impact of cellular pathophysiology.
Starling
Mark R
MR
The University of Michigan and VA Healthcare Systems, Ann Arbor, Mich. 48105, USA. mrstar@umich.edu
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002908:Chronic Disease; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000188:drug therapy* / Q000503:physiopathology*; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy* / Q000503:physiopathology*
D000319:Adrenergic beta-Antagonists